Phillip Securities Research

Broker's Calls

Analysts positive on FCT after 'steady operating metrics' posted in 3QFY2023 business update

CGS-CIMB, Maybank and Phillip Securities have maintained their positive calls with unchanged TPs of $2.62, $2.35 and $2.35.

Broker's Calls

SAC Capital sees First REIT’s improved risk profile offering sustainable DPU

SAC Capital analyst Yeo Peng Joon has initiated coverage for the REIT with a ‘buy’ call and TP of 30 cents.

Investing strategies

2022: A year of reopening, rate hike and GST increase

After a false start in 2021, economic reopening is deemed inevitable, says Phillip Securities' Terence Chua.

Broker's Calls

Analyst remain bullish as Oxley goes into cash conservation mode for survival

"Cash flow survival is key," analysts say. Oxley has $150 million of bonds maturing in May 2020, which are expected to be redeemed with existing cash.

Investing 101

To sell, hold – or buy even more? What should investors do amid falling stock prices?

How to mitigate your losses, and make a profit during these times.
What to do during a stock market crash

Investing 101

What to do during a stock market crash

Find out how to survive a market crash and protect your investments.

Broker's Calls

'Cash is king': Top 20 cash rich companies to ride out the market tailspin

Can their strong balance sheets help these companies ride out the market tailspin better than others?
When is the best time to buy and sell stocks

Investing 101

When is the best time to buy stocks?

Study the charts, identify a good bargain, and study the company’s fundamentals to determine when your stock price has hit rock bottom, and if it is worth buying in during this time.

Investing ideas

This healthcare stock could be a multibagger as share price plunges to all-time low

Phillip Securities Research forecasts that the company will clock another year of positive EBITDA in FY2020.

Investing ideas

ThaiBev could fizzle out amid coronavirus outbreak, stiffer drunk driving penalties, but analysts unfazed

Analysts are upgrading ThaiBev to "buy" despite the headwinds.
×